etherna

BIO-Europe is just around the corner! From November 4-6, our BIO-expert duo (David Ricketts and Bernard Sagaert) will represent us at BIO-Europe in Stockholm - their fourth major BIO conference this year! They have been active all year, attending BIO-Europe (Spring), BIO International, and BIO Japan - and they are not slowing down. They are excited to dive into discussions on the latest innovations, connect with partners, and explore collaborations that push the boundaries of mRNA LNP therapeutics and improve patients' lives. Don't miss the chance to meet Bernard or David in person. Drop a comment if you are attending, or reach out directly via the partnering platform to schedule a meeting. #BIOEUROPE #Stockholm #mRNA #LNP

𝗨𝗽𝗱𝗮𝘁𝗲 𝗳𝗿𝗼𝗺 𝗪𝗼𝗿𝗹𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗘𝘂𝗿𝗼𝗽𝗲! Today, Stefaan De Koker, our VP Technology & Innovation took the stage at The World Vaccine Congress in Barcelona on a groundbreaking topic: 𝗡𝗲𝘅𝘁-𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗺𝗥𝗡𝗔 𝗟𝗡𝗣 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀. Stefaan shared his insights into how our research can change the fight against malaria. 𝗛𝗮𝗹𝗳 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱'𝘀 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗮𝘁 𝗿𝗶𝘀𝗸 𝗼𝗳 𝗰𝗼𝗻𝘁𝗿𝗮𝗰𝘁𝗶𝗻𝗴 𝗺𝗮𝗹𝗮𝗿𝗶𝗮 and our mRNA LNP technology could transform how we address this global healthcare challenge. We are proud to be at the forefront of this innovative journey and look forward to sharing more developments as we continue to push the boundaries of vaccine science. A big thank you to our team and partners who are driving these advances, and to The World Vaccine Congress for providing a platform to showcase the future of vaccines. #WVCEU #mRNA #LNP #Vaccine #Malaria

We are proud that two of our team members, Bernard Sagaert and Phil Challis, were involved in these important discussions hosted by the Alliance for mRNA Medicines. Their engagement in the latest policy and technology discussions shows our commitment to staying at the forefront of mRNA advancements. We look forward to the impact these insights will have on the industry. #AMM #mRNA #HealthcareLeaders

𝗣𝗿𝗼𝘂𝗱 𝘁𝗼 𝗯𝗲 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 𝗮𝘁 𝗺𝗥𝗡𝗔 𝗛𝗲𝗮𝗹𝘁𝗵 𝗶𝗻 𝗕𝗼𝘀𝘁𝗼𝗻! We are attending mRNA Health 2024, taking place from November 12 - 14 at the Boston Convention & Exhibition Center.  Our team will share the latest advancements in mRNA and LNP technology. Stefaan De Koker, VP Technology & Innovation, will present, and Florence Lambolez, Director of Pharmacology, will give a poster presentation. In addition, you can meet with our CEO, Bernard Sagaert, Pete Smith, VP Business Development, and Shelly West, Director Business Development US. Don’t miss the chance to meet our team members, explore our innovations, and discuss the future of mRNA therapies. See you there!  #Vaccines #mRNA #RNA #LNP #Boston #mRNAHealth2024

𝗪𝗲𝗹𝗰𝗼𝗺𝗲 𝘁𝗼 𝗼𝘂𝗿 𝘁𝗲𝗮𝗺! Last month, we welcomed not only one but two new colleagues to our team. 🥼 Lisanne Vennens has joined us as QA Associate, bringing her keen eye for quality and detail to ensure our high standards. 🥼Veronica Mavrovouna stepped in as our new Research Associate In Vitro Pharmacology, where she will dive into advancing our in vitro research efforts. Veronica will be taking over from Jurgen Van den Heuvel, who is going off on an exciting sabbatical adventure in Sweden! We wish him all the best on his journey and would like to see him back in November 2025. Let's give Lisanne and Veronica a warm welcome and wish Jurgen good luck on his next chapter! #WelcomeAboard #QualityAssurance #Pharmacology #LNPs #mRNA

𝗠𝗲𝗲𝘁 𝗦𝘁𝗲𝗳𝗮𝗮𝗻 𝗮𝘁 𝘁𝗵𝗲 𝗪𝗼𝗿𝗹𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗘𝘂𝗿𝗼𝗽𝗲!   We are excited that Stefaan De Koker, VP Technology & Innovation, will be presenting at The World Vaccine Congress.   📆 Mark your calendars for 12:00 Noon (CET) on Monday, 28 October 2024. Stefaan will delve into “𝗧𝗵𝗲 𝗻𝗲𝘅𝘁 𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗺𝗥𝗡𝗔 𝗟𝗡𝗣 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀”. In particular, how these vaccines have demonstrated 𝗿𝗼𝗯𝘂𝘀𝘁 𝗶𝗺𝗺𝘂𝗻𝗶𝘁𝘆 𝗮𝗴𝗮𝗶𝗻𝘀𝘁 𝗺𝗮𝗹𝗮𝗿𝗶𝗮 in vivo. Based on his and the team at etherna's groundbreaking research, it paves the way for advancements in the fight against malaria. We are eager to share our insights with the global vaccine community to try and combat this devastating disease with an estimated 249 million cases leading to 𝟲𝟬𝟴,𝟬𝟬𝟬 𝗺𝗮𝗹𝗮𝗿𝗶𝗮 𝗱𝗲𝗮𝘁𝗵𝘀 𝗮𝗻𝗻𝘂𝗮𝗹𝗹𝘆.   Whether you are attending the Congress or following along, don’t miss this opportunity to learn more about the future of mRNA LNP technology.   #WVC2024 #Vaccines #mRNA #MalariaResearch #LipidNanoparticles #WVC

𝗢𝘂𝗿 𝘁𝗲𝗮𝗺 𝗺𝗲𝗺𝗯𝗲𝗿𝘀 𝗮𝘁 𝗕𝗜𝗢 𝗝𝗮𝗽𝗮𝗻   BIO Japan started, and our team members David Ricketts and Bernard Sagaert are ready for it. This event is a fantastic opportunity to connect and present our cutting-edge RNA & LNP technology to the Japanese market.   Thank you to Flanders Investment & Trade - Japan for making our participation possible. We are proud to be part of such a prestigious event.   If you are attending, don’t miss the chance to meet Bernard and David and explore how etherna shapes the future of RNA & LNP therapeutics. #BIOJapan #RNA #LNP #FITJapan #Yokohama #Networking

𝐂𝐨𝐧𝐠𝐫𝐚𝐭𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐭𝐨 𝐭𝐡𝐞 𝟐𝟎𝟐𝟒 𝐍𝐨𝐛𝐞𝐥 𝐏𝐫𝐢𝐳𝐞 𝐢𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐖𝐢𝐧𝐧𝐞𝐫𝐬!   We want to celebrate the 𝗿𝗲𝗺𝗮𝗿𝗸𝗮𝗯𝗹𝗲 𝗮𝗰𝗵𝗶𝗲𝘃𝗲𝗺𝗲𝗻𝘁 of Victor Ambros and Gary Ruvkun who were jointly awarded the prestigious 2024 Nobel Prize for Medicine. The award was for their discovery of 𝗺𝗶𝗰𝗿𝗼𝗥𝗡𝗔 𝗮𝗻𝗱 𝗶𝘁𝘀 𝗿𝗼𝗹𝗲 𝗶𝗻 𝗽𝗼𝘀𝘁-𝘁𝗿𝗮𝗻𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻𝗮𝗹 𝗴𝗲𝗻𝗲 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻. Their discoveries have paved the way for innovation, especially in gene activity, and continue to shape the future. We are inspired by their dedication and the 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝘃𝗲 𝗶𝗺𝗽𝗮𝗰𝘁 𝗥𝗡𝗔 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 are having on global health care. etherna was founded over 10 years ago to bring mRNA-based medicines to market. We are thrilled to see the attention that mRNA is being focussed on this field especially as this marks 𝘁𝗵𝗲 𝘀𝗲𝗰𝗼𝗻𝗱 𝗰𝗼𝗻𝘀𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝘆𝗲𝗮𝗿 that the Nobel Prize for Medicine 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘇𝗲𝘀 𝘁𝗵𝗲 𝗶𝗻𝗰𝗿𝗲𝗱𝗶𝗯𝗹𝗲 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗼𝗳 𝗥𝗡𝗔-𝗯𝗮𝘀𝗲𝗱 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵. #NobelPrize #NobelPrize2024 #RNAResearch #RNAtherapeutics #Innovation

𝗧𝗿𝘆 𝗼𝘂𝗿 𝗺𝗥𝗡𝗔 𝘆𝗼𝘂𝗿𝘀𝗲𝗹𝗳, 𝗻𝗼𝘄 𝟮𝟬% 𝗼𝗳𝗳! Over the last two weeks, we have 𝗱𝗲𝗺𝗼𝗻𝘀𝘁𝗿𝗮𝘁𝗲𝗱 𝘁𝗵𝗲 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 of our mRNA with comprehensive data proving two key things: 1️⃣ Highest 𝗺𝗥𝗡𝗔 𝗶𝗻𝘁𝗲𝗴𝗿𝗶𝘁𝘆 (see https://lnkd.in/eHp5ZRY8) 2️⃣ Lowest 𝗱𝘀𝗥𝗡𝗔 𝗹𝗲𝘃𝗲𝗹𝘀 (and we know how critical this is in preventing adverse effects - see https://lnkd.in/exPW4Pr8) But don't just take our word for it - 𝘁𝗿𝘆 𝗶𝘁 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿𝘀𝗲𝗹𝗳. For one week only, we are 𝗼𝗳𝗳𝗲𝗿𝗶𝗻𝗴 𝘆𝗼𝘂 𝟮𝟬% 𝗼𝗳𝗳 on all our off-the-shelf materials. Place your order now or get in touch with one of our experts for more details (use the code RNA20). We are confident in our product's quality and we encourage you to experience it firsthand in your research. 👉 https://lnkd.in/e3k54NcN ✅Proven data ✅Superior quality ✅Now with 20% off until October 10 - don't miss out #RNAtechnology #mRNAresearch #dsRNAsafety

𝗪𝗲 𝗮𝗿𝗲 𝗵𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 𝗕𝗶𝗼 𝗝𝗮𝗽𝗮𝗻 𝟮𝟬𝟮𝟰! We will be attending Bio Japan - Asia's largest biotech partnering event- for the first time! Bio Japan is taking place in 𝗬𝗼𝗸𝗼𝗵𝗮𝗺𝗮 𝗳𝗿𝗼𝗺 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟵 𝘁𝗼 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟭𝟭. Our team is eager to share our latest innovations and build new partnerships. Bernard Sagaert and David Ricketts are ready to engage with you on the future of RNA & LNP therapeutics. Don't miss the chance to connect with us! We look forward to meeting you at Bio Japan and thank Flanders Investment & Trade (FIT) for supporting our participation. #BIOJapan2024 #BiotechEvent #Yokohama #RNA #LNP